NCT02571855View on ClinicalTrials.gov

A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of ACT-541468 in Healthy Young Adults and Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

February 1, 2016

Study Completion Date

February 1, 2016

Conditions
Healthy Subjects
Interventions
DRUG

ACT-541468 (hydrochloride salt)

Hard-gelatin capsules (strength: 5 mg and 25 mg)

DRUG

ACT-541468 (free base)

Soft capsules (strength: 25 mg)

DRUG

Placebo

Placebo capsules matching the ACT-541468 formulations

Trial Locations (1)

Unknown

Investigator Site, Leiden

Sponsors
All Listed Sponsors
lead

Idorsia Pharmaceuticals Ltd.

INDUSTRY